A Democratic senator who many political observers believe will run for her party’s presidential nomination in 2020 is joining another possible contender in supporting the most far-reaching marijuana legislation ever to be considered in Congress.
Sen. Kirsten Gillibrand (D-NY) on Wednesday signed on as the latest cosponsor of the Marijuana Justice Act, a bill that Sen. Cory Booker (D-NJ) filed last August.
Watch as Gillibrand and Booker discuss the bill:
The bill would not only remove marijuana from the Controlled Substances Act so that states could legalize without federal interference, but would also withhold funding from states that maintain prohibition and continue racially disproportionate arrest and incarceration rates for cannabis.
In a Facebook Live video, Gillibrand cited the fact that marijuana usage rates are virtually identical across racial lines while people of color are more likely to be arrested, convicted and sentenced for it.
“The way our criminal justice system is working is so harmful, and so biased,” she said.
Booker praised states that are ending cannabis prohibition, but said that they also need to allow people who have been caught up in the failed war on drugs to participate in the newly legal economy.
“God bless you for legalizing marijuana,” he said. “But if that’s all we do, I am not satisfied. I am angry.”
The legislation would also require federal courts to expunge people’s prior marijuana convictions and would let people punished under disproportionately enforced cannabis laws to file civil lawsuits against those states.
Money withheld from states with discriminatory marijuana policies would be used to fund job training and libraries.
I’m proud to announce that I will be cosponsoring the Marijuana Justice Act introduced by my friend @CoryBooker We're going live from my Facebook page for a few minutes to talk about the bill. Join us! https://t.co/cdsMmZTADb
— Kirsten Gillibrand (@SenGillibrand) February 14, 2018
“Millions of Americans’ lives have been devastated because of our broken marijuana policies, especially in communities of color and low-income communities,” Gillibrand said in a press release about the bill. “Just one minor possession conviction could take away a lifetime of opportunities for jobs, education, and housing, tear families apart, and make people more vulnerable to serving time in jail or prison down the road. The reality that my 14-year-old son would likely be treated very differently from one of his Black or Latino peers if he was caught with marijuana is shameful. Legalizing marijuana is a social justice issue and a moral issue that Congress needs to address, and I’m proud to work with Senator Booker on this legislation to help fix decades of injustice caused by our nation’s failed drug policies.”
“Legalizing marijuana isn’t a matter of if, it’s a matter of when. I’m thrilled Senator Gillibrand has joined me in this movement to make our justice system more fair. The War on Drugs has been a war on people, especially people of color and low-income individuals.The Marijuana Justice Act would reverse this trend by not only legalizing marijuana, but by also helping to address the damage the War on Drugs has inflicted on communities disproportionately impacted by marijuana enforcement.”
Sen. Ron Wyden (D-OR) signed on as the bill’s first cosponsor in December.
Congresswoman Barbara Lee (D-CA) filed a companion bill in the House last month. It currently has 24 cosponsors.
Booker and Gillibrand have worked together over the past two congresses to sponsor far-reaching medical cannabis legislation.
The two also joined 16 other senators this week in signing a letter calling for new far-reaching protections for state marijuana laws to be inserted into federal spending legislation.
Photo courtesy of personaldemocracy.
Marijuana Isn’t Addictive, Former A.G. Eric Holder Says
The nation’s former top law enforcement officer is not worried that the legalization of marijuana will lead to addiction.
“I’ve never seen any scientific evidence that points you to concerns about addiction through the use of marijuana,” former U.S. Attorney General Eric Holder said in an interview published on Friday by NY1.
The comments by the former A.G. call into question cannabis’s current status as a Schedule I drug. That category is supposed to be reserved only for substances with no medical value and a high potential for abuse. In fact, it would mean that marijuana should be moved to at least Schedule III, where drugs with “moderate to low potential for physical and psychological dependence” are categorized.
Although Holder did not move to reclassify cannabis when he had the power to do so as attorney general, he did specifically endorse such a change just months after leaving office.
“I certainly think it ought to be rescheduled,” he said in a 2015 interview with PBS.
And he still feels the same way.
“We need to move marijuana from Schedule I, so research can be done,” Holder said in the new NY1 interview. “It is classified now on the same level as heroin is, and clearly that is inappropriate.”
While he did nothing to officially recategorize marijuana as attorney general — and continually passed the buck to Congress when asked about the issue — Holder’s Justice Department did issue guidance, known as the Cole Memo, which generally allowed states to implement their own cannabis laws without federal interference.
Current Attorney General Jeff Sessions rescinded that memo earlier this year.
In the new interview, Holder said he thinks the federal government should continue letting states implement their own legalization laws.
“Let those be laboratories to see where we want to be,” he said. “I think if you allow the states to experiment we’ll ultimately come to a national consensus about what it is we ought to do with regard to marijuana.”
He also spoke about unfair enforcement of cannabis criminalization.
“One of the things that I am concerned about, though, is the racial disparity you see in the enforcement of marijuana laws,” he said. “You see African Americans, Latinos using marijuana at just about the same rates as whites, and yet seeing rates of arrest four, five times as great as it is for whites. That is something that I think is extremely troubling.”
Photo courtesy of US Embassy New Zealand.
Congressional Committee Protects Medical Marijuana From Jeff Sessions
A powerful congressional panel voted on Thursday to continue shielding medical marijuana patients and providers who comply with state laws from prosecution by the federal government.
While the provision has been federal law since 2014, when it was first attached to legislation that funds the U.S. Department of Justice, its continuance has been in question because of recent efforts by Republican leadership to prevent votes on cannabis amendments. But in a stunning bipartisan move, the House Appropriations Committee voted to add the provision as a rider to legislation funding U.S. Attorney General Jeff Session’s department for Fiscal Year 2019.
(Marijuana Moment’s editor provides some content to Forbes via a temporary exclusive publishing license arrangement.)
Congressional Republicans Block Votes On Hemp Amendments
In the latest development in a series of anti-cannabis moves, congressional Republican leadership has blocked consideration of several industrial hemp amendments.
Supporters were seeking to attach the measures to the large-scale Farm Bill, which sets food and agriculture policy for the country, but the House Rules Committee on Wednesday decided that the proposals cannot be considered on the floor.
The anti-cannabis chairman of the panel did, however, reveal that a broader deal for industrial hemp might be in the works.
One of the measures the committee killed, submitted by Reps. James Comer (R-KY) and Earl Blumenauer (D-OR), along with a bipartisan list of cosponsors, would have legalized hemp and made it eligible for crop insurance.
“Hemp is a crop with a long and rich history in our country,” Comer said in introducing his amendment before the committee. “It was grown by many of our founding fathers.”
Comer, who is a former Kentucky agriculture commissioner, said his state’s existing industrial hemp research program, which is authorized under a previous Farm Bill enacted in 2014, “has been a great success.”
He also spoke about the economic potential of the plant. “Times are tough in rural america,” he said. “For rural Kentuckians, industrial hemp has provided a new crop and business opportunity.”
But in a party-line move, the committee voted 8 to 3 to reject a motion to add Comer’s amendment to the list of proposals approved for floor consideration.
Another hemp amendment, filed by Reps. Thomas Massie (R-KY) and Jared Polis (D-CO), would have removed hemp from the list of federally banned substances.
A third proposal, submitted by Rep. Andy Barr (R-KY), sought to create “a safe harbor for financial institutions that provide services to hemp legitimate businesses” that operate under state-authorized research programs.
“There is a proud history in American and in Kentucky [for hemp] as an agriculture product,” Barr said when testifying for his amendment, noting that it can be used in over 25,000 products.
Under current law, banks that work with legitimate hemp companies “fear reprisal from federal regulators,” Barr said, arguing that his proposed measure would protect financial institutions “from unnecessary interference from bank examiners and regulators” and give producers rights that “every other American crop enjoys.”
The committee did not hold specific votes on those two measures.
Rules Committee Chairman Pete Sessions (R-TX) has made a consistent practice of blocking cannabis measures from advancing over the past several years.
Sessions, seemingly mistakenly, told Comer during the Wednesday hearing that the U.S. Drug Enforcement Administration (DEA) has “a clause…that industrial hemp should be declassified under their Schedule I drugs, which they concur, which is the position you hold, too.”
A hemp lobbyist told Marijuana Moment in an email that he had not heard of the DEA taking a pro-hemp position.
Polis, who as a Rules Committee member made the unsuccessful motion to let the full House vote on Comer’s amendment, argued that hemp is a “common sense area” that enjoys bipartisan support. The measure, he said, would simply “treat industrial hemp as the agricultural commodity that it is.”
While Sessions and other GOP panel members were not swayed, the chairman did hint just before the vote that there may still be hope for hemp reform, saying that the issue would be “determined by an agreement that would be reached” with Senate Majority Leader Mitch McConnell (R-KY).
McConnell last month filed a hemp legalization bill, which Comer’s amendment closely modeled. Fully a fifth of the Senate is now signed on as cosponsoring that legislation, and the majority leader has already announced plans to attach his hemp language to the version of the Farm Bill being considered by the Senate this month.
While it is unclear what exactly Sessions was suggesting when he referred to an “agreement” with McConnell, it may have been a reference to the conference committee process that will merge the House and Senate’s respective versions of the Farm Bill into a single proposal after each chamber passes its legislation. If McConnell succeeds in attaching hemp legalization to the Senate bill, it would then be up for consideration as part of the final legislation sent to President Trump for signing into law.
In 2014, McConnell successfully inserted a provision to prevent federal interference in hemp research programs in that year’s version of the Farm Bill.
Photo courtesy of Chris Wallis // Side Pocket Images.